Position
SIMPLEX TRADING, LLC in Nektar Therapeutics
Back to the book · All holders of NKTR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $169.8K$42.28 → $71.95
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 21.9K | $927.5K | — | — | — | 0.0% |
| Q1 2026 | 5.72K | $411.7K | $71.95 | $169.8K | −$685.5K | 0.0% |